Wird geladen...
Contemporary Treatment of Metastatic Renal Cell Carcinoma
The introduction of targeted therapy has revolutionized the treatment of patients with metastatic renal cell carcinoma (mRCC). The current standard of care focuses on the inhibition of angiogenesis through the targeting of the vascular endothelial growth factor receptor (VEGFR) and the mammalian tar...
Gespeichert in:
| Veröffentlicht in: | Oncol Rev |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
PAGEPress Publications, Pavia, Italy
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4943094/ https://ncbi.nlm.nih.gov/pubmed/27471582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/oncol.2016.295 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|